Multiple Assemblies exist for SMTL entry 4qoc
crystal structure of compound 16 bound to MDM2(17-111), {(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOPROPYL-2-(PYRROLIDIN-1-YLSULFONYL)ETHYL]-3-METHYL-2-OXOPIPERIDIN-3-YL}ACETIC ACID; X-RAY DIFFRACTION 1.70 Å

	SMTL ID 4qoc.1 Ligands {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(pyrrolidin-1-ylsulfonyl)ethyl]-3-methyl-2-oxopiperidin-3-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4qoc.2 Ligands {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(pyrrolidin-1-ylsulfonyl)ethyl]-3-methyl-2-oxopiperidin-3-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4qoc.3 Ligands {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(pyrrolidin-1-ylsulfonyl)ethyl]-3-methyl-2-oxopiperidin-3-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4qoc.4 Ligands {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(pyrrolidin-1-ylsulfonyl)ethyl]-3-methyl-2-oxopiperidin-3-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4qoc.5 Ligands {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(pyrrolidin-1-ylsulfonyl)ethyl]-3-methyl-2-oxopiperidin-3-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer
	SMTL ID 4qoc.6 Ligands {(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(pyrrolidin-1-ylsulfonyl)ethyl]-3-methyl-2-oxopiperidin-3-yl}acetic acid Polypeptides E3 ubiquitin-protein ligase Mdm2 Oligo-state monomer